Published in Transl Psychiatry on March 06, 2012
Gene x abstinence effects on drug cue reactivity in addiction: multimodal evidence. J Neurosci (2013) 0.95
Amphetamine self-administration attenuates dopamine D2 autoreceptor function. Neuropsychopharmacology (2014) 0.90
Circadian rhythms and addiction: mechanistic insights and future directions. Behav Neurosci (2014) 0.87
Genetic variation and dopamine D2 receptor availability: a systematic review and meta-analysis of human in vivo molecular imaging studies. Transl Psychiatry (2016) 0.80
Genetics and epigenetics of circadian rhythms and their potential roles in neuropsychiatric disorders. Neurosci Bull (2015) 0.79
Minutes, days and years: molecular interactions among different scales of biological timing. Philos Trans R Soc Lond B Biol Sci (2014) 0.79
Circadian regulation gene polymorphisms are associated with sleep disruption and duration, and circadian phase and rhythm in adults with HIV. Chronobiol Int (2015) 0.78
Circadian Mechanisms Underlying Reward-Related Neurophysiology and Synaptic Plasticity. Front Psychiatry (2016) 0.78
NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity. J Reward Defic Syndr (2015) 0.77
The mPer2 clock gene modulates cocaine actions in the mouse circadian system. Behav Brain Res (2013) 0.77
Early avoidance of a heroin-paired taste-cue and subsequent addiction-like behavior in rats. Brain Res Bull (2015) 0.77
New repeat polymorphism in the AKT1 gene predicts striatal dopamine D2/D3 receptor availability and stimulant-induced dopamine release in the healthy human brain. J Neurosci (2017) 0.76
Excessive state switching underlies reversal learning deficits in cocaine users. Drug Alcohol Depend (2013) 0.76
Reduced sleep duration mediates decreases in striatal D2/D3 receptor availability in cocaine abusers. Transl Psychiatry (2016) 0.76
Circadian Dysregulation in Parkinson's Disease. Neurobiol Sleep Circadian Rhythms (2016) 0.75
mPer1 promotes morphine-induced locomotor sensitization and conditioned place preference via histone deacetylase activity. Psychopharmacology (Berl) (2017) 0.75
Mapping determinants of human gene expression by regional and genome-wide association. Nature (2005) 17.24
Signals of recent positive selection in a worldwide sample of human populations. Genome Res (2009) 8.38
Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science (2007) 6.75
Genetics in geographically structured populations: defining, estimating and interpreting F(ST). Nat Rev Genet (2009) 5.23
The genetics of addictions: uncovering the genes. Nat Rev Genet (2005) 5.05
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci (2006) 4.98
Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol (2009) 4.70
Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex (2000) 4.61
Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse (1993) 4.13
Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci U S A (2007) 3.92
Drug addiction: the neurobiology of behaviour gone awry. Nat Rev Neurosci (2004) 3.13
Recent acceleration of human adaptive evolution. Proc Natl Acad Sci U S A (2007) 3.13
Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc Natl Acad Sci U S A (2007) 3.06
From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat Rev Genet (2009) 2.98
Disentangling the effects of demography and selection in human history. Mol Biol Evol (2004) 2.97
Variable tandem repeats accelerate evolution of coding and regulatory sequences. Annu Rev Genet (2010) 2.89
Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci (2009) 2.78
Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci U S A (2011) 2.62
Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol (2011) 2.51
Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry (1999) 2.49
Cocaine sensitization and reward are under the influence of circadian genes and rhythm. Proc Natl Acad Sci U S A (2002) 2.40
New approaches to disease mapping in admixed populations. Nat Rev Genet (2011) 2.22
Transposon-mediated rewiring of gene regulatory networks contributed to the evolution of pregnancy in mammals. Nat Genet (2011) 2.22
Roles for nigrostriatal--not just mesocorticolimbic--dopamine in reward and addiction. Trends Neurosci (2009) 2.09
D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet (2003) 1.95
Food and drug reward: overlapping circuits in human obesity and addiction. Curr Top Behav Neurosci (2012) 1.90
Transposable elements: powerful facilitators of evolution. Bioessays (2009) 1.82
Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry (1990) 1.66
Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson's disease. Eur J Neurol (2009) 1.58
Regulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation. PLoS One (2010) 1.44
A cline in the Drosophila melanogaster period gene in Australia: neither down nor under. J Evol Biol (2007) 1.44
Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area. J Neurosci (2005) 1.43
Argonaute 2 in dopamine 2 receptor-expressing neurons regulates cocaine addiction. J Exp Med (2010) 1.40
Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology (2010) 1.29
Human population differentiation is strongly correlated with local recombination rate. PLoS Genet (2010) 1.28
Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. J Neurosci (2010) 1.28
Clines in clock genes: fine-tuning circadian rhythms to the environment. Trends Genet (2008) 1.23
Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol. Psychiatry Res (1996) 1.22
Phenotypic effects of genetic variability in human clock genes on circadian and sleep parameters. J Genet (2008) 1.15
Gene x disease interaction on orbitofrontal gray matter in cocaine addiction. Arch Gen Psychiatry (2011) 1.14
A silent polymorphism in the PER1 gene associates with extreme diurnal preference in humans. J Hum Genet (2006) 1.13
Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light. J Pineal Res (2004) 1.11
Lewis and Fischer rats: a comparison of dopamine transporter and receptors levels. Brain Res (1998) 1.10
Circadian rhythms in gene expression: Relationship to physiology, disease, drug disposition and drug action. Adv Drug Deliv Rev (2010) 1.10
Regulation of psychostimulant-induced signaling and gene expression in the striatum. J Neurochem (2008) 1.07
Electroencephalographic sleep and mood during cocaine withdrawal. J Addict Dis (1992) 1.06
PER2 variantion is associated with depression vulnerability. Am J Med Genet B Neuropsychiatr Genet (2010) 1.03
Sleep architecture, cocaine and visual learning. Addiction (2008) 1.03
Gene - environment interactions determine the individual variability in cocaine self-administration. Neuropharmacology (2005) 0.94
Dopamine receptor-mediated regulation of neuronal "clock" gene expression. Neuroscience (2008) 0.91
Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3' UTR VNTR of the DAT: association with childhood ADHD in male African-Caribbean cocaine dependents? Am J Med Genet B Neuropsychiatr Genet (2007) 0.89
Genetic diversity patterns at the human clock gene period 2 are suggestive of population-specific positive selection. Eur J Hum Genet (2008) 0.88
Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function. Clin Neuropharmacol (2002) 0.88
Association study between the DAT1, DBH and DRD2 genes and cocaine dependence in a Spanish sample. Psychiatr Genet (2010) 0.86
Human clock, PER1 and PER2 polymorphisms: lack of association with cocaine dependence susceptibility and cocaine-induced paranoia. Psychiatr Genet (2006) 0.86
Association analysis between polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with cocaine dependence. Neurosci Lett (2010) 0.85
Clock reset for alcoholism. Nat Med (2005) 0.80
A coalescent simulation of marker selection strategy for candidate gene association studies. Am J Med Genet B Neuropsychiatr Genet (2008) 0.77
Complex divergence at a microsatellite marker C1_2_5 in the lineage of HLA-Cw/-B haplotype. J Hum Genet (2009) 0.76
Mutation of human short tandem repeats. Hum Mol Genet (1993) 14.03
Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab (1996) 9.49
Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science (1997) 8.24
Brain dopamine and obesity. Lancet (2001) 8.00
Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol (1995) 7.86
Junior doctors' hours. Members of Junior Doctors Committee are in cloud cuckoo land. BMJ (1995) 7.84
Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab (1990) 6.62
Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature (1988) 6.01
Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature (1997) 4.82
Optical coherence tomography of macular holes. Ophthalmology (1995) 4.64
Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex (2000) 4.61
A study of the quality of life and cost-utility of renal transplantation. Kidney Int (1996) 4.51
Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol (1995) 4.47
Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry (2001) 4.37
Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry (2001) 4.13
Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse (1993) 4.13
The relationship of the spleen to the formation of the blood corpuscles. J Physiol (1902) 3.98
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry (2004) 3.80
Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature (1997) 3.76
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46
The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol Cell Biol (1986) 3.36
Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int (2000) 3.29
Imaging dopamine's role in drug abuse and addiction. Neuropharmacology (2008) 3.28
Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection. Proc Natl Acad Sci U S A (1984) 3.11
Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry (1998) 3.02
Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature (1997) 2.94
Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry (1991) 2.89
The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am (1993) 2.85
Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nat Genet (1995) 2.62
Inhibition of monoamine oxidase B in the brains of smokers. Nature (1996) 2.62
p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. Genes Dev (1999) 2.58
Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry (1999) 2.50
Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry (1998) 2.50
Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry (1999) 2.49
Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci (2001) 2.41
Deletion of the gene encoding the adenovirus 5 early region 1b 21,000-molecular-weight polypeptide leads to degradation of viral and host cell DNA. J Virol (1984) 2.39
Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev (1998) 2.39
Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sci (1999) 2.35
Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc Natl Acad Sci U S A (1998) 2.32
Transcription termination within the E1A gene of adenovirus induced by insertion of the mouse beta-major globin terminator element. Cell (1985) 2.29
Effect of a media-led education campaign on breast and cervical cancer screening among Vietnamese-American women. Prev Med (1999) 2.28
Evidence for reduced recombination on the nondisjoined chromosomes 21 in Down syndrome. Science (1987) 2.27
Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol Cell Biol (1997) 2.25
Long-term frontal brain metabolic changes in cocaine abusers. Synapse (1992) 2.16
Concentration and occupancy of dopamine transporters in cocaine abusers with [11C]cocaine and PET. Synapse (1997) 2.15
Isolation of a glucan-binding domain of glucosyltransferase (1,6-alpha-glucan synthase) from Streptococcus sobrinus. Infect Immun (1988) 2.13
Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. J Pharmacol Exp Ther (1999) 2.11
New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol Psychiatry (2011) 2.11
Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res (1996) 2.09
Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann Neurol (1989) 2.08
Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med (1978) 2.07
Hospitalization in an urban homeless population: the Honolulu Urban Homeless Project. Ann Intern Med (1992) 2.04
Optical coherence tomography of central serous chorioretinopathy. Am J Ophthalmol (1995) 2.03
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry (2011) 2.03
A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med (1980) 2.01
Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry (1995) 2.00
Obesity and addiction: neurobiological overlaps. Obes Rev (2012) 1.99
Aging and functional brain networks. Mol Psychiatry (2011) 1.99
Is hand, foot and mouth disease associated with meteorological parameters? Epidemiol Infect (2010) 1.99
Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation (1996) 1.99
Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav Pharmacol (2002) 1.95
Role of the anterior cingulate and medial orbitofrontal cortex in processing drug cues in cocaine addiction. Neuroscience (2006) 1.93
Food and drug reward: overlapping circuits in human obesity and addiction. Curr Top Behav Neurosci (2012) 1.90
Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol Carcinog (1991) 1.87
Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am J Psychiatry (2000) 1.85
Smads bind directly to the Jun family of AP-1 transcription factors. Proc Natl Acad Sci U S A (1999) 1.81
Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. Am J Psychiatry (1999) 1.81
Is [1-11C]putrescine useful as a brain tumor marker? J Nucl Med (1992) 1.80